Usage, impact écologique et économique des antifongiques systémiques en milieu hospitalier en France, Bull Epidémiologique Hebd, issue.12?13, pp.117-120, 2013. ,
Revue de??pertinence des??prescriptions des??nouveaux antifongiques syst??miques dans??un??h??pital universitaire, M??decine et Maladies Infectieuses, vol.37, issue.3, pp.223-228, 2007. ,
DOI : 10.1016/j.medmal.2007.05.009
Audit clinique des prescriptions d???antifongiques syst??miques couteux au centre hospitalier universitaire de Besan??on, M??decine et Maladies Infectieuses, vol.39, issue.2, pp.125-132, 2009. ,
DOI : 10.1016/j.medmal.2008.09.028
Combination Antifungal Therapy, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.693-715, 2004. ,
DOI : 10.1128/AAC.48.3.693-715.2004
Empirical versus Preemptive Antifungal Therapy for High???Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial, Clinical Infectious Diseases, vol.48, issue.8, pp.1042-1051, 2009. ,
DOI : 10.1086/597395
A 6?year antifungal stewardship programme in a teaching hospital REFERENCES: 1 Invasive fungal infections among organ transplant recipients: results of the Transplant?Associated Infection Surveillance Network (TRANSNET), Infection. Clin Infect Dis Off Publ Infect Dis Soc Am, vol.4150, issue.38, pp.621-6281101, 2010. ,
The changing epidemiology of invasive fungal infections: new threats, International Journal of Antimicrobial Agents, vol.27, issue.1, pp.3-6, 2006. ,
DOI : 10.1016/j.ijantimicag.2006.03.006
Mycoses invasives en France métropolitaine, PMSI 2001?20100: incidence, létalité et tendances, Bull Epidémiologique Hebd, issue.12?13, pp.109-114, 2013. ,
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-163, 2007. ,
DOI : 10.1128/CMR.00029-06
Advances and challenges in management of invasive mycoses, The Lancet, vol.366, issue.9490, pp.1013-1025, 2005. ,
DOI : 10.1016/S0140-6736(05)67381-3
Beta?D?glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients? Clin Infect Dis Off Publ Infect Dis Soc Am, pp.886-889, 2008. ,
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients, Bone Marrow Transplantation, vol.48, issue.6, pp.846-854, 2012. ,
DOI : 10.1128/JCM.01466-10
Difficultés de diagnostic et d'expertise microbiologique des infections fongiques invasives, Bull Epidémiologique Hebd, issue.12?13, p.115117, 2013. ,
Usage, impact écologique et économique des antifongiques systémiques en milieu hospitalier en France, Bull Epidémiologique Hebd, issue.12?13, p.117120, 2013. ,
Revue de??pertinence des??prescriptions des??nouveaux antifongiques syst??miques dans??un??h??pital universitaire, M??decine et Maladies Infectieuses, vol.37, issue.3, pp.223-228, 2007. ,
DOI : 10.1016/j.medmal.2007.05.009
Combination Antifungal Therapy, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.693-715, 2004. ,
DOI : 10.1128/AAC.48.3.693-715.2004
Empirical versus Preemptive Antifungal Therapy for High???Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial, Clinical Infectious Diseases, vol.48, issue.8, pp.1042-1051, 2009. ,
DOI : 10.1086/597395
A 6-year antifungal stewardship programme in a teaching hospital, Infection, vol.18, issue.3, pp.621-628, 2013. ,
DOI : 10.1111/j.1469-0691.2012.03973.x
A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital, Clinical Microbiology and Infection, vol.19, issue.1, pp.56-61, 2013. ,
DOI : 10.1111/j.1469-0691.2012.03891.x